News / Science News

    Scientists A Step Closer to Drug Treatment for Hepatitis B

    A major new insight into how hepatitis B virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide.



    Scientists a step closer to drug treatment for hepatitis B.


    The team at the Universities of York and Leeds identified an "assembly code" in the genetic material of Hepatitis B Virus that allows it to create a protective casing in which it can produce new infectious virus particles.

    They found that the signal, generated by ribonucleic acid (RNA), helps viral proteins to overcome an 'engineering problem', assembling them into in a particular geometric pattern.

    The virus is transmitted through blood and bodily fluids. It is thought that more than two billion people have been infected worldwide, and around 350 million people remain carriers of the infection, which can, over time, result in their deaths.

    The virus occurs in Europe but is much more common in parts of Asia, especially China and Africa.

    There is a vaccine for the virus, but once you have the condition there is no treatment, other than drugs that can reduce symptoms but not change the long-term outlook.

    The researchers are already collaborating with a team at the National Institutes of Health in the USA to identify potential drug candidates that are capable of breaking the link between RNA and proteins which should halt viral replication. (Tasnim News Agency)

    JUNE 26, 2017



    YOU MAY ALSO LIKE

    A new research suggests that time of day exercise is completed may impact its physical effects.
    An international study has found that white people have difficulty distinguishing emotions on black people’s faces—a problem that does not appear to arise the other way around.
    Other than their purity, flaws in Diamonds may be holding the key to a new type of communications with high security. Diamonds were used by researchers to preserve fragile quantum information over long distances.
    Researchers from the University of Granada, University Hospital La Paz (Madrid) and the University of Texas (USA) have identified a new molecular mechanism underlying the anti-obesity effects of the chronic administration of melatonin, a naturally occurring hormone released by the pineal gland overnight.
    Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease.
    Moderately reducing caloric intake over a period of two years significantly improved cardiometabolic risk factors in young and middle-aged, non-obese adults, according to new findings from the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact